0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cinryze C1 Drug Insight, 2019
Published Date: February 2019
|
Report Code: DELV-DRIN-11
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Cinryze C1 Drug Insight 2019

Cinryze C1 Drug Insight, 2019

Code: DELV-DRIN-11
Report
February 2019
Pages:35
Delveinsight
Description
Table of Content
Tables & Figures

Introduction
DelveInsight's pharmaceuticals report, "Cinryze C1 Drug Insight, 2019" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Cinryze C1 covering the historical global sales and also provides the Cinryze C1 sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Cinryze C1 and emerging therapies in this space.

Methodology
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope
• A review of the Cinryze C1, based on information derived from company and industry-specific sources
• Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the Drug Master Files and API Manufacturers by country
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Forecasted Sales Figure from 2019-2021
• Market competition and emerging therapies
• SWOT Analysis

Reasons to Buy
• Establish a comprehensive understanding of Cinryze C1
• Access to drug`s API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around drug`s patents for the major markets- US and EU
• Understand Cinryze C1`s current and future growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for the drug
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
• Identify opportunities in the same area as Cinryze C1 with DelveInsight`s SWOT analysis

  1. DelveInsight Report Introduction
    2. Cinryze C1- Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Regulatory Milestones by Region
    • Deals and Partnerships
    3. Product Details
    4. Cinryze C1 Sales Assessment
    • Historical Sales
    • Forecasted Sales
    5. Patent Details
    6. Global API Manufacturers Assessment
    • Active Pharmaceutical Ingredient (API) Manufacturers by Country
    • Active Pharmaceutical Ingredient (API) Manufacturers by Region
    7. Market Competition
    8. Emerging Therapies
    8.1 Drug 1: Company 1
    • Product Description
    • Research and Development
    • Product Development Activities
    9. SWOT Analysis
    Appendix
    Methodology
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer

List of Tables

Table 1: Cinryze C1, Description
Table 2: Product Details
Table 3: Cinryze C1, Historical Sales till 2018 (in million USD)
Table 4: Cinryze C1, Forecasted Sales from 2019-2021 (in million USD)
Table 5: Patent Details
Table 6: API Manufacturers by country
Table 7: API Manufacturers by Region
Table 8: Cinryze C1 Major Competitors
Table 9: Emerging Therapies

List of Figures

Figure 1: Cinryze C1, Historical Global Sales till 2018 (in million USD)
Figure 2: Cinryze C1, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 3: API Manufacturers by country
Figure 4: API Manufacturers by Region

SELECT A FORMAT
Added to Cart
Electronic (PDF)

$1000

This license allows only one user to access the PDF.
Electronic (PDF)

$2000

This license allows all the users of an enterprise residing in one location to access the PDF
Electronic (PDF)

$3000

This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Animal Insulin Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25R900
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global EGFR Mutation Test Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20Z6130
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Adenosine Injection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-21W3671
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ultrasonic Probes Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6A910
Mon Apr 15 00:00:00 UTC 2024

Add to Cart